THE EFFECT OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ON WORK PARTICIPATION IN LONGSTANDING RHEUMATOID ARTHRITIS: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

被引：1
|
作者：
Alunno, A. [1 ]
Marques, M. L. [2 ,3 ]
Falzon, L. [4 ]
Ramiro, S. [2 ,5 ]
Boonen, A. [6 ]
机构：
[1] Univ LAquila, Dept Life Hlth & Environm Sci, Internal Med & Nephrol Unit, Laquila, Italy
[2] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[3] Coimbra Univ Hosp, Dept Rheumatol, Coimbra, Portugal
[4] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England
[5] Zuyderland Med Ctr, Dept Rheumatol, Herleen, Netherlands
[6] Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.3562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0364
引用
收藏
页码：1309 / 1309
页数：1
相关论文
共 50 条
  • [21] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Xerxes Pundole
    Natalia V. Zamora
    Harish Siddhanamatha
    Heather Lin
    Jean Tayar
    Leung Cheuk Hong
    Liang Li
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2020, 39 : 787 - 794
  • [22] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Pundole, Xerxes
    Zamora, Natalia V.
    Siddhanamatha, Harish
    Lin, Heather
    Tayar, Jean
    Hong, Leung Cheuk
    Li, Liang
    Suarez-Almazor, Maria E.
    CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 787 - 794
  • [23] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
  • [24] The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [25] Summary of indirect comparisons to evaluate efficacy of baricitinib with targeted synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Emery, P.
    Dudler , J.
    Smolen, J.
    Zerbini, C.
    Burmester, G.
    Fautrel, B.
    van de Laar, M.
    Fleischmann, R.
    Fakhouri, W.
    De Leonardis, F.
    Zhu, B.
    Kadziola, Z.
    De La Torre, I
    Perrier, C.
    Taylor, P.
    SWISS MEDICAL WEEKLY, 2019, : 7S - 8S
  • [26] Retention Rate and Safety of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease: Results from the KOBIO Registry
    Kim, Ji-Won
    Lee, Sun-Kyung
    Jung, Ju-Yang
    Suh, Chang-Hee
    Shin, Kichul
    Kim, Hyoun-Ah
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1819 - 1821
  • [27] Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature
    Boleto, Goncalo
    Drame, Moustapha
    Lambrecht, Isabelle
    Eschard, Jean-Paul
    Salmon, Jean-Hugues
    CLINICAL RHEUMATOLOGY, 2017, 36 (08) : 1699 - 1706
  • [28] Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature
    Gonçalo Boleto
    Moustapha Dramé
    Isabelle Lambrecht
    Jean-Paul Eschard
    Jean-Hugues Salmon
    Clinical Rheumatology, 2017, 36 : 1699 - 1706
  • [29] Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Garrood, T
    Scott, DL
    BIODRUGS, 2001, 15 (08) : 543 - 561
  • [30] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
12345